有机碘化物(三甲基碘硅烷)
Search documents
博苑股份:公司依托“产品+资源综合利用”的特色商业模式为客户提供全方位服务
Zheng Quan Ri Bao Wang· 2025-11-27 08:44
Core Viewpoint - The company, Boyuan Co., Ltd. (301617), is a high-tech enterprise specializing in the research, production, and sales of fine chemicals, emphasizing a unique business model that integrates product offerings with resource recycling [1] Group 1: Business Model and Product Offerings - Boyuan Co., Ltd. has developed a diverse product matrix, including organic iodides (trimethyl iodide), inorganic iodides (potassium iodate, potassium iodide, hydrogen iodide), and luminescent materials, leading in their respective niche markets [1] - The company provides essential raw materials and additives to various industries such as pharmaceuticals, optoelectronics, chemicals, and entertainment, leveraging years of technical accumulation and market presence [1] Group 2: Industry Standards and Influence - The company actively participates in the establishment of industry standards, having contributed to the formulation of 3 industry standards and 11 group standards, which enhances its professional influence in niche markets [1] Group 3: Resource Recycling and Economic Benefits - Boyuan Co., Ltd. is one of the few companies in the industry that effectively combines its main products with resource recycling, operating as a circular economy enterprise [1] - The company procures waste materials generated during production from clients or other businesses, extracting key raw materials, thus addressing waste disposal challenges for upstream companies while reducing its own procurement costs [1] Group 4: Integrated Services and Client Relationships - The company offers a full industrial chain service, from basic chemical raw material supply to hazardous waste resource utilization and product processing, establishing mutually beneficial strategic partnerships with major clients [1] - This approach significantly enhances customer loyalty and strengthens the company's core market competitiveness [1] Group 5: Future Business Expansion - Looking ahead, Boyuan Co., Ltd. plans to expand its business into new materials and new energy sectors, aiming to extend its industrial chain and contribute to the development of a green low-carbon economy [1]
调研速递|博苑股份接待证券时报等2家媒体采访 循环经济模式降本增效 新质生产力布局高端材料
Xin Lang Cai Jing· 2025-11-27 01:16
Core Viewpoint - The company, Boyuan Co., Ltd., is focusing on enhancing its market position through a circular economy model, new material and energy strategies, and a comprehensive development plan for the 14th Five-Year Plan period [1][8]. Group 1: Business Model and Market Position - Boyuan Co., Ltd. specializes in fine chemical products, establishing a competitive edge in the market through a diverse product matrix that includes organic and inorganic iodides, as well as luminescent materials [3]. - The company has participated in the formulation of 3 industry standards and 11 group standards, enhancing its influence in the fine chemical sector [3]. - The business model integrates resource utilization by sourcing production waste from upstream companies, which reduces procurement costs and addresses waste disposal challenges [3]. Group 2: Circular Economy and Cost Management - The company has developed a circular economy model centered on the recovery of iodine and precious metals, significantly lowering raw material dependency and production costs [4]. - This model mitigates risks associated with price fluctuations of imported raw materials while achieving both economic and environmental benefits [4]. - The iodine resource recovery business is noted for its advanced recycling processes and large-scale handling capabilities, positioning the company as a leader in the industry [4]. Group 3: New Material and Energy Development - In response to national strategies for developing new productive forces, Boyuan Co., Ltd. is actively investing in high-tech, high-value-added new materials and energy sectors [5]. - The company is increasing R&D investments and enhancing its innovation center to accelerate the commercialization of research outcomes [5]. - Automation and smart technology upgrades in production processes are being implemented to transition towards high-end, intelligent, and green industries [5]. Group 4: Mergers and Acquisitions Strategy - The company maintains an open attitude towards mergers and acquisitions, aiming to evaluate potential targets that offer technological synergies or resource alignment [6]. Group 5: 14th Five-Year Plan Focus - The company’s 14th Five-Year Plan emphasizes five key areas for high-quality development, including talent cultivation, R&D, market expansion, governance, and investor returns [8]. - A comprehensive talent management system is being established to attract and retain skilled professionals, aligning with the company’s growth and technical needs [8]. - The company aims to enhance its governance and investor confidence through strict fund management and transparent information disclosure [8]. Group 6: Green Development and Compliance - Boyuan Co., Ltd. is committed to green and low-carbon development by optimizing production processes to reduce energy consumption and emissions [9]. - The company plans to align with local industrial layouts and regulatory guidelines to support sustainable regional economic development [9].
博苑股份(301617) - 2025年11月26日投资者关系活动记录表
2025-11-27 00:30
证券代码:301617 证券简称:博苑股份 编号:2025-017 | | □特定对象调研 □分析师会议 | | | --- | --- | --- | | 投资者关系活 ☑ 动类别 | 媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □现场参观 □其他(请文字说明其他活动内容) | | | 参与单位名称 | 证券时报、大众日报 | | | 及人员姓名 | | | | 时间 | 年 11 月 26 日 | 2025 | | 地点 | 博苑股份会议室 | | | 上市公司接待 | 1、董事长:李成林 | | | | 2、常务副总经理:王恩训 | | | 人员姓名 | 3、财务总监:孙腾 | | | | 4、证券事务代表:杨艳丽 | | | | 媒体主要提问及答疑: | | | | 1、作为一家化学品公司,公司在细分行业的市场地位如 | | | | 何?对行业产业集聚以及经济发展起到的推动和促进作用如 | | | | | 何? | | | 答:博苑股份是一家专业从事精细化学品研发、生产、销 | | | | 售及资源综合利用的高新技术企业,经过多年深耕,公司依托 | | | 投资者 ...
博苑股份(301617) - 301617博苑股份投资者关系管理信息20250925
2025-09-25 09:50
Group 1: Iodine Applications and Market Overview - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations as key components or catalysts [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, collectively accounting for approximately 63% of global consumption [2] - Major iodine production is concentrated in three regions: Chile, Japan, and the United States, which together account for 88% of global sales [2] Group 2: Iodine Production and Market Share - Five companies in Chile account for about 60% of global iodine sales, with SQM alone representing approximately 37% [2] - Eight Japanese producers collectively hold around 23% of the market share, while U.S. producers account for nearly 5% [2] - Other countries with minor production include Russia, Turkmenistan, Azerbaijan, Indonesia, and China [3] Group 3: Company Product Offerings - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, primarily used in pharmaceuticals, pesticides, feed, and optoelectronic materials [3] - The company’s organic iodide product, trimethylsilyl iodide, serves as a protecting group in organic synthesis, mainly applied in pharmaceutical production (e.g., cephalosporins, macrolide antibiotics) [3] - The company has a 4,000 tons/year inorganic iodide production project focusing on potassium iodide, hydriodic acid, ammonium iodide, silver iodide, and lithium iodide [3]
博苑股份:公司现有产品无机碘化物主要包括碘化钾、碘酸钾、碘化钠、氢碘酸、碘化亚铜等
Zheng Quan Ri Bao Zhi Sheng· 2025-09-12 10:12
Group 1 - The company announced on September 12 that its existing inorganic iodides include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, which are primarily used in pharmaceuticals, pesticides, animal feed, and optoelectronic materials [1] - The company's organic iodide product, trimethyl iodide silane, serves as a functional group protecting agent in organic synthesis, mainly applied in the pharmaceutical field, such as the production of cephalosporins and macrolide antibiotics [1]